Bottom line
IXJ vs SCHLX: the short answer
IXJ (iShares Global Healthcare ETF) and SCHLX (DWS Health and Wellness Fund) are both etfs.
IXJ is cheaper at 0.38% vs 1.06% — a difference of $68 a year per $10,000 invested.
Updated Nov 19, 2026
IXJ vs SCHLX side by side
| IXJ | SCHLX | |
|---|---|---|
| Type | ETF | Mutual fund |
| Fund family | iShares | DWS (Xtrackers) |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 0.38% | 1.06% |
| Annual cost per $10k | $38 | $106 |
| 10-yr cost on $10k (prospectus) | $480 | $1,294 |
| Max front load | None | 0% |
| 12b-1 fee | 0% | 0% |
| 1-yr return | +14.9% | — |
| 5-yr return (annualized) | +6.4% | — |
| 10-yr return (annualized) | +8.2% | — |
| Best quarter | +13.6% | — |
| Worst quarter | −11.8% | — |
| Net assets (fund) | $3.8B | $231.8M |
| Number of holdings | 124 | 65 |
| Portfolio turnover | 2% | 2% |
| Returns as of | Dec 31, 2025 | — |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
18 of IXJ's top 25 holdings also appear in SCHLX's top 25.
| Holding | IXJ | SCHLX |
|---|---|---|
| Eli Lilly And Company | 10.93% | 13.85% |
| Johnson & Johnson | 7.04% | 6.19% |
| Abbvie Inc. | 5.12% | 4.90% |
| Unitedhealth Group Incorporated | 4.40% | 5.73% |
| Merck & Co., Inc. | 4.12% | 4.85% |
| Astrazeneca Plc | 3.76% | 3.80% |
| Roche Holding AG | 3.75% | 1.24% |
| Amgen Inc. | 2.54% | 2.88% |
| Thermo Fisher Scientific Incorporated | 2.42% | 3.46% |
| Abbott Laboratories | 2.05% | 2.39% |
| Gilead Sciences, Inc. | 2.04% | 2.78% |
| Intuitive Surgical, Inc. | 1.83% | 2.69% |
| Pfizer Inc. | 1.78% | 1.17% |
| Vertex Pharmaceuticals Incorporated | 1.64% | 2.45% |
| Danaher Corporation | 1.56% | 2.13% |
Source: SEC Form N-PORT
IXJ top 10
- Eli Lilly And Company — 10.93%
- Johnson & Johnson — 7.04%
- Abbvie Inc. — 5.12%
- Unitedhealth Group Incorporated — 4.40%
- Merck & Co., Inc. — 4.12%
- Astrazeneca Plc — 3.76%
- Roche Holding AG — 3.75%
- Novartis AG — 3.71%
- Amgen Inc. — 2.54%
- Thermo Fisher Scientific Incorporated — 2.42%
SCHLX top 10
- Eli Lilly & Co — 13.85%
- Johnson & Johnson — 6.19%
- UnitedHealth Group Inc — 5.73%
- AbbVie Inc — 4.90%
- Merck & Co Inc — 4.85%
- AstraZeneca PLC — 3.80%
- Thermo Fisher Scientific Inc — 3.46%
- Novartis AG — 2.90%
- Amgen Inc — 2.88%
- Gilead Sciences Inc — 2.78%
FAQ
What is the difference between IXJ and SCHLX?
IXJ (iShares Global Healthcare ETF) and SCHLX (DWS Health and Wellness Fund) are both etfs. IXJ is cheaper at 0.38% vs 1.06% — a difference of $68 a year per $10,000 invested.
Which is cheaper, IXJ or SCHLX?
IXJ has the lower expense ratio (0.38%).
Should I own both IXJ and SCHLX?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.